Picture of GSK logo

GSK GSK Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for GSK, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,0964,9215,3082,9516,289
Depreciation
Amortisation
Non-Cash Items1,2522,4331,9921,5041,643
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-773-2,098-2,826-452-3,969
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities7,9527,4036,7686,5547,741
Capital Expenditures-2,931-2,258-2,344-2,982-2,985
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1,154-6,5147491,753-1,248
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-1,777-8,772-1,595-1,229-4,233
Financing Cash Flow Items-1,4019,089-837-910-1,024
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-7,589823-5,641-4,726-3,685
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,443-394-567545-196